Motherson Sumi Systems, consolidated profit during the quarter ended March 31,2018, rose by 9.2 % year-on-year to Rs.518.4 crore. The company in the same quarter last year...
Aurobindo Pharma has received 9 Form 483 observations from USFDA, for its Unit IV injectable facility. Unit IV is situated in Pashamailaram near Hyderabad, where it...